United Therapeutics Corporation Net Income 2008–2025
United Therapeutics Corporation reported $1.33B of net income for fiscal 2025. That was 11.7% higher than fiscal 2024.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $1.33B | 41.9% | +11.7% |
| FY 2024 | $1.20B | 41.5% | +21.4% |
| FY 2023 | $984.80M | 42.3% | +35.4% |
| FY 2022 | $727.30M | 37.6% | +52.9% |
| FY 2021 | $475.80M | 28.2% | — |
| FY 2020 | $0 | 0.0% | +100.0% |
| FY 2019 | $-104.50M | -7.2% | -117.7% |
| FY 2018 | $589.20M | 36.2% | +41.0% |
| FY 2017 | $417.90M | 24.2% | -41.4% |
| FY 2016 | $713.70M | 44.6% | +9.5% |
| FY 2015 | $651.60M | 44.5% | — |
| FY 2014 | $0 | 0.0% | — |
| FY 2013 | $0 | 0.0% | — |
| FY 2012 | $0 | 0.0% | — |
| FY 2011 | $0 | 0.0% | -100.0% |
| FY 2010 | $105.92M | 17.9% | +444.2% |
| FY 2009 | $19.46M | 5.4% | +139.5% |
| FY 2008 | $-49.33M | -17.5% | — |
Source: United Therapeutics Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open UTHR 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
United Therapeutics Corporation reported $1.33B of net income for fiscal 2025. That was 11.7% higher than fiscal 2024. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for United Therapeutics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeUnited Therapeutics Corporation — frequently asked questions
What is United Therapeutics Corporation's net income?
United Therapeutics Corporation (UTHR) reported net income of $1.33B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from United Therapeutics Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.